Cellerant Therapeutics   Report issue

For profit Phase 2
Founded: San Carlos CA United States (2003)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2009
NCT00891137
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now